Sven Ante Lundberg Merus N.V. (MRUS) insider trading activity

Sven Ante Lundberg is President, CEO & PEO of Merus N.V.. Currently has a direct ownership of 30,297 shares of MRUS, which is worth approximately $1.93 Million. The most recent transaction as insider was on Apr 17, 2025, when has been sold 30,297 shares (Common Shares) at a price of $13.03 per share, resulting in proceeds of $394,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.3K

0% 3M change

25.33% 12M change

Total Value Held $1.93 Million

Sven Ante Lundberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 17 2025	BUY Exercise of conversion of derivative security	$394,769 $13.03 p/Share	30,297 Added 50.0%	30,297 Common Shares
Feb 19 2025	SELL Bona fide gift	-	40,601 Reduced 100.0%	0 Common Shares
Feb 13 2025	BUY Exercise of conversion of derivative security	$399,967 $24.43 p/Share	16,372 Added 28.74%	40,601 Common Shares
Nov 03 2022	BUY Open market or private purchase	$211,472 $14.38 p/Share	14,706 Added 26.6%	40,576 Common Shares
Aug 22 2022	BUY Open market or private purchase	$133,532 $22.92 p/Share	5,826 Added 18.38%	25,870 Common Stock
Aug 19 2022	BUY Open market or private purchase	$16,185 $22.99 p/Share	704 Added 3.39%	20,044 Common Stock
Jul 12 2022	BUY Open market or private purchase	$99,690 $22.97 p/Share	4,340 Added 18.33%	19,340 Common Shares
Aug 02 2021	BUY Exercise of conversion of derivative security	$195,450 $13.03 p/Share	15,000 Added 50.0%	15,000 Common Shares
Mar 25 2021	SELL Bona fide gift	-	74,000 Reduced 100.0%	0 Common Shares
Mar 01 2021	BUY Exercise of conversion of derivative security	$964,220 $13.03 p/Share	74,000 Added 50.0%	74,000 Common Shares

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

Chief Scientific Officer

VOR

Vor Biopharma Inc. Healthcare

FIXX

Homology Medicines, Inc. Healthcare

SAL